Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

By Yahoo! Finance | Aug 3, 2024 at 09:51 AM EST

Puma Biotechnology exceeded market expectations in its recent quarterly results, with revenues beating forecasts by 5.4%. Analysts anticipate a 43% increase in earnings per share for 2024, showing improved sentiment towards the company's future prospects.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.